Originally Published EMDM May/June 2005
Industry News
Smart Sensors Target Implanted Applications
Two companies have joined forces to develop low-power sensors with wireless capability for implanted medical applications. The devices will be able to diagnose and treat a range of conditions from inside the body, according to Bio-Nano Sensium Technologies, a joint venture between Toumaz Technology Ltd. (Abingdon, Oxon, UK) and Advance Nanotech Inc. (London).
The new firm is currently focusing on refining the information and communication systems technology that the sensors require to interact with their surrounding environment. The underlying technology builds on research conducted at London’s Imperial College of Science, Technology, and Medicine on ultra-low-power circuits and systems. Toumaz exploited that research to produce advanced mixed-signal and wireless transceiver devices. Its AMx technology enables the design of products that consume dramatically less power than current state-of-the-art microprocessors. The next evolutionary step for the firm is the development of implantable sensors.
Bio-Nano Sensium products will be based on industry-standard CMOS technology to allow low-cost production. The platform technology is sufficiently mature, according to Advance Nanotech, for the commercialization process to go forward quite rapidly.
For more information, contact Advance Nanotech Inc., Savannah House, 11-12 Charles II Street, London SW1Y 4QU, UK; phone: +44 207 4512466; fax: +44 207 4512469; e-mail: info@advancenanotech.com; Internet: www.advancenanotech.com.
Copyright ©2005 European Medical Device Manufacturer
